Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Stop Panicking!

<< Previous

Bullboard Posts

Next >>

Comment by Angler101on Oct 26, 2023 9:35am

146 Views

Post# 35701844

RE:Stop Panicking!

Zak....great post...the entire biotech sector is down 25%!....what that shows is the market is shorting Oncy along with the entire sector....and this shows a level of common sense that far surpasses the absolute garbage that fox just posted...keep up the good fight bro.....I think we're going to see some gains this coming week leading up to earnings report and update.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"